ASD in pharmaceutical industry
To meet the strict requirements of your business, DEVEA brings its expertise in aerial surface disinfection (ASD) at the service of pharmaceutical industry professionals.
How can DEVEA technology meet the needs of the pharmaceutical industry?
Despite your most rigorous processes, your production rooms can still be contaminated (conditioner, filler, airlock).
Terminal disinfection can help you improve the safety of your products and boost productivity. DEVEA’s goal is to provide the pharmaceutical industry with the highest standard of disinfection (log6).
We offer a wide range of machines and extensive expertise to achieve the best possible results. Our know-how in ASD for the pharmaceutical industry can help you achieve a zero contamination level.
ASD in pharmaceutical industry: a look into Devea's solutions
Phileas uses the unique and innovative Microdrop technology.
The MicroDrop Technology developed by DEVEA ensures a perfectly homogeneous, replicable and optimal treatment in the processed volumes.
The combination of Phileas machines and either O2Safe or Phileasafe disinfectants guarantees the effectiveness of the disinfection. This O2Safe®-Phileas® pair has been granted the Marketing Authorisation (AMM ANSES N. FR-2019-0071).
All tests required by the EN 17-272 standard have been performed by independent laboratories. Our wide range of machines, such as the Phileas® Genius (0,5 m3- 5m3), the Phileas® 75 (up to 165m3) and the Phileas® 250 (800m3) allow us to address the challenges of the pharmaceutical industry.
Devea’s ASD solutions for the pharmaceutical industry have been proven effective.
Our ASD methodology for the pharmaceutical industry
The ASD methodology in the pharmaceutical industry is similar to that applied in other industries. However, the process may be different in the context of a MSC or laboratory space disinfection.
Need identification
We are careful to establish a diagnosis of the situation to identify the specific needs of our clients.
Machine selection
Following the diagnosis, we select the most suitable ASD machine.
Testing with chemical or biological indicators
Tests are carried out upstream before launching the complete hygiene process.
Replicability of tests
Tests are reproduced for best results.
Deployement
The complete ASD process can now be started.
Our goal is to provide pharmaceutical industry professionals with an ultimate solution.
What are the outcomes of ASD in the pharmaceutical industry?
The effectiveness of the Phileas® / O2Safe® process has been proven in many practical cases > Log G6. DEVEA has the expertise to guarantee these results. Our mobile systems, their reduced volume and easy maintenance provide you with a durable high-performance solution.
The most suitable products for your industry
Phileas® 25
The Phileas® 25 is a very nomadic device. Its exclusive multi-cycle program allows it treat small area such as airlocks, isolators, RABS or biosafety cabinet.
Phileas® 75
Equipped with an integrated precision scale, the Phileas® 75 is one of the most popular products in the pharmaceutical industry because of its autonomy and flexibility.
Phileas® 250
The Phileas® 250, is equipped with a precision scale- and two diffusion heads, it is particularly suitable for sterile production zones, large laboratories and long corridors.